MTOR and prostate carcinoma: mTOR regulates EMT in prostate cancer through the RhoA and Rac1 pathways.[58] Transcriptomic analysis and omics validation showed that mTOR expression was reduced by both SHP099 and embelin, explaining the reversal of EMT at the molecular level.